ITGAX and hairy cell leukemia: Hairy cell leukemia (HCL) is a chronic neoplasm of mature B cells, expressing some distinctive surface markers (i.e., CD103, CD25 and CD11c), which can be exploited for MRD evaluation, by using both immunohistochemistry (IHC) [100] and MFC [101].